Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03936959 |
| Title | A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA | BEL | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| St Vincent's Hospital | Sydney | New South Wales | 2010 | Australia | Details | |
| Universitair Ziekenhuis Gent | Gent | 9000 | Belgium | Details | ||
| Institut Claudius Regaud - IUCT Oncopole | Toulouse cedex 9 | 31059 | France | Details | ||
| Asan Medical Center | Songpa-gu | Seoul | 05505 | Korea, Republic of | Details |